ginkgobioworks.comHealthcare / BioTech & PharmaFounded: 2008Funding to Date: $785.53MM
Ginkgo Bioworks is the developer of a cell programming platform enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/28/2020 | Series E | $360MM | $xx.xx | $4.89B | Allen & Company, Baillie Gifford, Cascade Investment, General Atlantic, Illumina, Reshape Holdings, T. Rowe Price, Viking Global Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,396,964
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Allen & Company, Baillie Gifford, Cascade Investment, General Atlantic, Illumina, Reshape Holdings, T. Rowe Price, Viking Global Investors
|
||||||
12/14/2017 | Series D | $275MM | $xx.xx | $1.57B | Cascade Investment, General Atlantic, Viking Global Investors, Vital Venture Capital, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
5,763,991
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cascade Investment, General Atlantic, Viking Global Investors, Vital Venture Capital, Y Combinator
|
||||||
06/08/2016 | Series C | $98.9MM | $xx.xx | $450MM | Allen & Company, Alrai Capital, Baillie Gifford, Cascade Investment, Casdin Capital, Senator Investment Group, Viking Global Investors, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
4,658,503
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Allen & Company, Alrai Capital, Baillie Gifford, Cascade Investment, Casdin Capital, Senator Investment Group, Viking Global Investors, Y Combinator
|
||||||
07/08/2015 | Series B | $51.63MM | $xx.xx | $200MM | Chinarock Capital Management, Data Collective, Felicis Ventures, Id Ventures America, Iglobe Partners, Ken Arnold, Massventures, Os Fund, Vast Ventures, Viking Global Investors, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
4,024,260
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chinarock Capital Management, Data Collective, Felicis Ventures, Id Ventures America, Iglobe Partners, Ken Arnold, Massventures, Os Fund, Vast Ventures, Viking Global Investors, Y Combinator
|